Dyne Therapeutics Inc (DYN)
23.87
+0.22
(+0.93%)
USD |
NASDAQ |
Apr 19, 16:00
23.87
0.00 (0.00%)
After-Hours: 18:29
Dyne Therapeutics Cash from Financing (Quarterly): 0.147M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.147M |
| September 30, 2023 | 0.454M |
| June 30, 2023 | 24.91M |
| March 31, 2023 | 28.82M |
| December 31, 2022 | 37.20M |
| September 30, 2022 | 0.07M |
| June 30, 2022 | 0.099M |
| March 31, 2022 | 0.018M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.089M |
| September 30, 2021 | 0.457M |
| June 30, 2021 | 0.025M |
| March 31, 2021 | 157.25M |
| December 31, 2020 | -11.19M |
| September 30, 2020 | 379.98M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 11.91M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-11.19M
Minimum
Dec 2020
379.98M
Maximum
Sep 2020
39.39M
Average
0.3005M
Median
Cash from Financing (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 0.391M |
| Solid Biosciences Inc | 0.505M |
| Avidity Biosciences Inc | 31.89M |
| Sana Biotechnology Inc | 1.718M |
| Tenaya Therapeutics Inc | 0.371M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.01M |
| Cash from Investing (Quarterly) | 26.20M |
| Free Cash Flow | -188.89M |
| Free Cash Flow Per Share (Quarterly) | -0.5714 |
| Free Cash Flow Yield | -13.26% |